To further evaluate the clinical significance of NETs in CRC patients, we measured the preoperative serum level of MPO–DNA in 67 patients with stages II and III CRC, as serum MPO–DNA is a reliable marker of systemic NET formation [27]. The gene discussed is MPO; the disease is colorectal carcinoma.